Janssen Seeks to Expand Use of ERLEADA® (apalutamide) in the Treatment of Patients with Metastatic Hormone-Sensitive Prostate Cancer
Application supported by data from the Phase 3 TITAN study which were recently presented at the 2019 ASCO Annual Meeting…